Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - HEALTH DISCOVERY CORP | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 17, 2013
Health Discovery Corporation
(Exact name of registrant as specified in charter)
|
Georgia
|
333-62216
|
74-3002154
|
|
(State of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
620 County Road, Hansson, MA 02341
(Address of principal executive offices / Zip Code)
678-336-5300
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act.
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.
|
| ITEM 8.01. | Other InformationOther Information |
On May 17, 2013, the Company issued the shareholder letter attached hereto as Exhibit 99.1.
| ITEM 9.01. | Financial Statements and Exhibits. |
| (a) | Not applicable |
| (b) | Not applicable |
| (c) | Not applicable |
| (d) | Exhibits. |
|
99.1 Press Release dated May 17, 2013
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HEALTH DISCOVERY CORPORATION
|
|||
|
|
|||
|
Dated: May 17, 2013
|
By:
|
/s/ John A. Norris, J.D., MBA
|
|
|
Chief Executive Officer
|
|||